{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T18:27:46Z","timestamp":1793212066633,"version":"4.5.0"},"reference-count":36,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2019,8,7]],"date-time":"2019-08-07T00:00:00Z","timestamp":1565136000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"name":"Department of Pathology at Mount Sinai Hospital"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,3,13]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background and Aims<\/jats:title>\n                  <jats:p>Small bowel adenocarcinoma [SBA] is a recognised complication of Crohn\u2019s disease [CD], but its low absolute prevalence limits opportunities for clinicopathological characterisation.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>We compared the clinical, pathological, and molecular features of 48 SBA from patients with CD [CDSBA] and 29 SBAs from patients without CD [NSBA] who underwent treatment at our tertiary care centre between 2000 and 2018.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Patients with CDSBA were younger than those with NSBA [mean age, 56 vs 64; p = 0.02]. Males predominated in both groups. Most CDSBA [69%] occurred in the ileum, whereas most NSBA occurred in the duodenum [38%] and jejunum [31%; p &amp;lt; 0.001]. Stage I tumours were more prevalent in the CDSBA [33% vs 3%; p = 0.002], although the rates of Stage IV disease and disease-specific mortality were similar in both groups. CDSBA were less likely to present a discrete mass [35% vs 93%; p &amp;lt; 0.001] and were more often stricturing or fistulising [75% vs 10%, respectively, p &amp;lt; 0.001] than NSBA. Microscopically, CDSBA were relatively heterogeneous, exhibiting at least three distinct growth patterns in 39% compared with 1% of NSBA [p = 0.01]. Low-grade tubuloglandular adenocarcinoma was the predominant pattern in 19% of CDSBA compared with 0% of NSBA [p = 0.003]. CDSBA were more frequently DNA mismatch repair proficient [90% vs 62%; p = 0.04] and exhibited profiles of frequently mutated genes similar to those of NSBA, except for IDH1 [18%] and SMAD4 [12%] mutations that occurred uniquely in CDSBA.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>These observations, based on the largest single-centre series described hitherto, establish that CDSBA is a distinct clinical, pathological, and molecular entity.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ecco-jcc\/jjz135","type":"journal-article","created":{"date-parts":[[2019,8,7]],"date-time":"2019-08-07T02:14:42Z","timestamp":1565144082000},"page":"287-294","source":"Crossref","is-referenced-by-count":28,"title":["Clinicopathological and Molecular Characterisation of Crohn\u2019s Disease-associated Small Bowel Adenocarcinomas"],"prefix":"10.1093","volume":"14","author":[{"given":"Xiaoyan","family":"Liao","sequence":"first","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, University of Rochester Medical Center, Rochester, NY, USA"},{"name":"Department of Pathology, Mount Sinai Hospital, New York, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangyuan","family":"Li","sequence":"first","affiliation":[{"name":"Department of Pathology, Mount Sinai Hospital, New York, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Russel","family":"McBride","sequence":"first","affiliation":[{"name":"Department of Pathology, Mount Sinai Hospital, New York, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane","family":"Houldsworth","sequence":"first","affiliation":[{"name":"Department of Pathology, Mount Sinai Hospital, New York, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noam","family":"Harpaz","sequence":"first","affiliation":[{"name":"Department of Pathology, Mount Sinai Hospital, New York, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandros D","family":"Polydorides","sequence":"first","affiliation":[{"name":"Department of Pathology, Mount Sinai Hospital, New York, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2019,8,7]]},"reference":[{"key":"2020042909355378100_CIT0001","first-page":"243","article-title":"The epidemiology of cancer of the small bowel","volume":"7","author":"Neugut","year":"1998","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"2020042909355378100_CIT0002","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/SLA.0b013e31818e4641","article-title":"Small bowel cancer in the United States: changes in epidemiology, treatment, and survival over the last 20 years","volume":"249","author":"Bilimoria","year":"2009","journal-title":"Ann Surg"},{"key":"2020042909355378100_CIT0003","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.dld.2013.04.013","article-title":"Small bowel adenocarcinoma: epidemiology, risk factors, diagnosis and treatment","volume":"46","author":"Aparicio","year":"2014","journal-title":"Dig Liver Dis"},{"key":"2020042909355378100_CIT0004","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1097\/00054725-200401000-00005","article-title":"Small intestinal adenocarcinoma in Crohn\u2019s disease: a case-control study","volume":"10","author":"Solem","year":"2004","journal-title":"Inflamm Bowel Dis"},{"key":"2020042909355378100_CIT0005","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1111\/j.1365-2036.2004.01858.x","article-title":"Intestinal and extra-intestinal cancer in Crohn\u2019s disease: follow-up of a population-based cohort in Copenhagen County, Denmark","volume":"19","author":"Jess","year":"2004","journal-title":"Aliment Pharmacol Ther"},{"key":"2020042909355378100_CIT0006","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S0889-8553(05)70065-0","article-title":"Cancer risk in patients with inflammatory bowel disease","volume":"28","author":"Lewis","year":"1999","journal-title":"Gastroenterol Clin North Am"},{"key":"2020042909355378100_CIT0007","first-page":"935183","article-title":"Small bowel adenocarcinoma complicating coeliac disease: a report of three cases and the literature review","volume":"2012","author":"Benhammane","year":"2012","journal-title":"Case Rep Oncol Med"},{"key":"2020042909355378100_CIT0008","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1158\/1055-9965.EPI-10-1281","article-title":"Crohn\u2019s disease and small bowel adenocarcinoma: a population-based case-control study","volume":"20","author":"Shaukat","year":"2011","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"2020042909355378100_CIT0009","first-page":"1823","article-title":"Incidence, presentation, and prognosis of small bowel adenocarcinoma in patients with small bowel Crohn\u2019s disease: a prospective observational study","volume":"19","author":"Elriz","year":"2013","journal-title":"Inflamm Bowel Dis"},{"key":"2020042909355378100_CIT0010","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1002\/jso.21505","article-title":"Ulcerative colitis and cancer","volume":"101","author":"Kulaylat","year":"2010","journal-title":"J Surg Oncol"},{"key":"2020042909355378100_CIT0011","doi-asserted-by":"crossref","first-page":"9872","DOI":"10.3748\/wjg.v20.i29.9872","article-title":"Colorectal cancer in inflammatory bowel disease: the risk, pathogenesis, prevention and diagnosis","volume":"20","author":"Kim","year":"2014","journal-title":"World J Gastroenterol"},{"key":"2020042909355378100_CIT0012","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1097\/MIB.0000000000000112","article-title":"Small bowel adenocarcinomas complicating Crohn\u2019s disease are associated with dysplasia: a pathological and molecular study","volume":"20","author":"Svrcek","year":"2014","journal-title":"Inflamm Bowel Dis"},{"key":"2020042909355378100_CIT0013","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1158\/1078-0432.CCR-11-1469","article-title":"Molecular pathways: microsatellite instability in colorectal cancer: prognostic, predictive, and therapeutic implications","volume":"18","author":"Sinicrope","year":"2012","journal-title":"Clin Cancer Res"},{"key":"2020042909355378100_CIT0014","doi-asserted-by":"crossref","first-page":"18654","DOI":"10.1073\/pnas.0704652104","article-title":"Integrated genetic and epigenetic analysis identifies three different subclasses of colon cancer","volume":"104","author":"Shen","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2020042909355378100_CIT0015","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1038\/nrc1507","article-title":"CpG island methylator phenotype in cancer","volume":"4","author":"Issa","year":"2004","journal-title":"Nat Rev Cancer"},{"key":"2020042909355378100_CIT0016","first-page":"343","article-title":"Adenocarcinoma of the small intestine in Crohn\u2019s disease","volume":"173","author":"Ribeiro","year":"1991","journal-title":"Surg Gynecol Obstet"},{"key":"2020042909355378100_CIT0017","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1007\/s11605-011-1441-x","article-title":"Small bowel adenocarcinoma in Crohn\u2019s disease","volume":"15","author":"Widmar","year":"2011","journal-title":"J Gastrointest Surg"},{"key":"2020042909355378100_CIT0018","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1111\/codi.13531","article-title":"Prognosis of small bowel adenocarcinoma in Crohn\u2019s disease compares favourably with de novo small bowel adenocarcinoma","volume":"19","author":"Wieghard","year":"2017","journal-title":"Colorectal Dis"},{"key":"2020042909355378100_CIT0019","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1097\/01.mib.0000179211.03650.b6","article-title":"Small bowel adenocarcinoma in patients with Crohn\u2019s disease compared with small bowel adenocarcinoma de novo","volume":"11","author":"Palascak-Juif","year":"2005","journal-title":"Inflamm Bowel Dis"},{"key":"2020042909355378100_CIT0020","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1007\/s00428-017-2125-z","article-title":"Small bowel adenocarcinoma complicating Crohn\u2019s disease: a single-centre experience emphasizing the importance of screening for dysplasia","volume":"471","author":"Grolleau","year":"2017","journal-title":"Virchows Arch"},{"key":"2020042909355378100_CIT0021","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1001\/jamaoncol.2017.1051","article-title":"Genomic profiling of small-bowel adenocarcinoma","volume":"3","author":"Schrock","year":"2017","journal-title":"JAMA Oncol"},{"key":"2020042909355378100_CIT0022","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1038\/modpathol.2017.40","article-title":"Small bowel carcinomas in celiac or Crohn\u2019s disease: distinctive histophenotypic, molecular and histogenetic patterns","volume":"30","author":"Vanoli","year":"2017","journal-title":"Mod Pathol"},{"key":"2020042909355378100_CIT0023","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1093\/ecco-jcc\/jjx031","article-title":"Small bowel carcinomas in coeliac or Crohn\u2019s disease: clinico-pathological, molecular, and prognostic features. A study from the Small Bowel Cancer Italian Consortium","volume":"11","author":"Vanoli","year":"2017","journal-title":"J Crohns Colitis"},{"key":"2020042909355378100_CIT0024","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/978-3-319-40618-3_18","article-title":"Small intestine.","volume-title":"AJCC Cancer Staging Manual","author":"Coit","year":"2017","edition":"8th"},{"key":"2020042909355378100_CIT0025","volume-title":"WHO Classification of Tumors of the Digestive System","author":"Bosman","year":"2010"},{"key":"2020042909355378100_CIT0026","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1097\/00000478-200608000-00014","article-title":"Intestinal low-grade tubuloglandular adenocarcinoma in inflammatory bowel disease","volume":"30","author":"Levi","year":"2006","journal-title":"Am J Surg Pathol"},{"key":"2020042909355378100_CIT0027","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1097\/PAS.0b013e31817ec2b1","article-title":"Pathologic predictors of microsatellite instability in colorectal cancer","volume":"33","author":"Greenson","year":"2009","journal-title":"Am J Surg Pathol"},{"key":"2020042909355378100_CIT0028","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1097\/PAS.0b013e318253645a","article-title":"Distinct clinicohistologic features of inflammatory bowel disease-associated colorectal adenocarcinoma: in comparison with sporadic microsatellite-stable and Lynch syndrome-related colorectal adenocarcinoma","volume":"36","author":"Liu","year":"2012","journal-title":"Am J Surg Pathol"},{"key":"2020042909355378100_CIT0029","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1097\/PAS.0000000000000239","article-title":"Isocitrate dehydrogenase-1 is mutated in inflammatory bowel disease-associated intestinal adenocarcinoma with low-grade tubuloglandular histology but not in sporadic intestinal adenocarcinoma","volume":"38","author":"Hartman","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"2020042909355378100_CIT0030","doi-asserted-by":"crossref","first-page":"2988","DOI":"10.1245\/s10434-014-4355-5","article-title":"Medullary colorectal carcinoma revisited: a clinical and pathological study of 102 cases","volume":"22","author":"Knox","year":"2015","journal-title":"Ann Surg Oncol"},{"key":"2020042909355378100_CIT0031","doi-asserted-by":"crossref","first-page":"e0212142","DOI":"10.1371\/journal.pone.0212142","article-title":"Clinicopathological characterization of SMAD4-mutated intestinal adenocarcinomas: a case-control study","volume":"14","author":"Liao","year":"2019","journal-title":"PLoS One"},{"key":"2020042909355378100_CIT0032","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s00384-013-1792-8","article-title":"Adenocarcinoma arising from a long-standing Kock pouch","volume":"29","author":"Giannini","year":"2014","journal-title":"Int J Colorectal Dis"},{"key":"2020042909355378100_CIT0033","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1007\/BF02258400","article-title":"Development of invasive adenocarcinoma in a long-standing Kock continent ileostomy: report of a case","volume":"40","author":"Cox","year":"1997","journal-title":"Dis Colon Rectum"},{"key":"2020042909355378100_CIT0034","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1053\/j.gastro.2016.04.001","article-title":"Genomic alterations observed in colitis-associated cancers are distinct from those found in sporadic colorectal cancers and vary by type of inflammatory bowel disease","volume":"151","author":"Yaeger","year":"2016","journal-title":"Gastroenterology"},{"key":"2020042909355378100_CIT0035","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1093\/annonc\/mdw013","article-title":"IDH mutations in cancer and progress toward development of targeted therapeutics","volume":"27","author":"Dang","year":"2016","journal-title":"Ann Oncol"},{"key":"2020042909355378100_CIT0036","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1038\/s41388-017-0077-z","article-title":"Wild-type and mutated IDH1\/2 enzymes and therapy responses","volume":"37","author":"Molenaar","year":"2018","journal-title":"Oncogene"}],"container-title":["Journal of Crohn's and Colitis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ecco-jcc\/advance-article-pdf\/doi\/10.1093\/ecco-jcc\/jjz135\/29311285\/jjz135.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/ecco-jcc\/article-pdf\/14\/3\/287\/32901514\/jjz135.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/ecco-jcc\/article-pdf\/14\/3\/287\/32901514\/jjz135.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,29]],"date-time":"2020-04-29T13:36:19Z","timestamp":1588167379000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ecco-jcc\/article\/14\/3\/287\/5544573"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,7]]},"references-count":36,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2019,8,7]]},"published-print":{"date-parts":[[2020,3,13]]}},"URL":"https:\/\/doi.org\/10.1093\/ecco-jcc\/jjz135","relation":{},"ISSN":["1873-9946","1876-4479"],"issn-type":[{"value":"1873-9946","type":"print"},{"value":"1876-4479","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,3]]},"published":{"date-parts":[[2019,8,7]]}}}